American Pacific nearing high purity Boric Acid production
American Pacific Borate & Lithium (ASX:ABR) has delivered a high 99%+ pure boric acid crystal with minimal impurities from its process optimisation works.
The process optimisation works were completed on April 10, which were designed to ensure the consistent delivery of a technical grade quality product from the company’s Fort Cady Borate Project.
ABR’s CEO Michael Schlumpberger commented on the results, “This is another hurdle completed in our aspiration to commence production of borates from our flagship Fort Cady Borate Project and ultimately to become a globally significant producer of high purity borate products.”
Process Optimisation Works
Since the completion of the Definitive Feasibility Study at Fort Cady, ABR has turned its attention to ensuring it can consistently deliver a technical grade premium boric acid product.
The results of these works have been very encouraging to date, with a final process now designed to ensure the highest grade product with minimal impurities will be delivered consistently by the project site.
The process includes:
- Treating liquor (Pregnant Leach Solution or PLS) that was retrieved on site from the Fort Cady orebody by solvent extraction, using isoctanol as the organic extractor.
- Further treating the resulting liquor in a scrubbing stage (sulfuric acid and ion-exchange) to purify liquor, and
- Crystallising the final liquor via a crystalliser manufacturer where the liquor was sent for evaluation and testing of the crystallisation steps of the process (as seen below).
“Our focus now turns to the completion of detailed engineering and securing the modest financing for the low capital starter project," Schlumpberger added.
“Importantly, we have delivered a very low capital starter project with brilliant financial metrics that sees us on a pathway to becoming a globally significant producer of borates targeting an EBTDA of over US$340 million per annum.
“When you consider borates are a vital input into new world technologies including electric vehicles, clean energy and food security related micro nutrients for optimal plant growth, we are sure demand for borates will only continue to grow.”
ABR commences funding stage
The company has now begun an informal process to secure funding for Phase 1A of the Fort Cade Borate Project. This process has tested lender appetite to significantly debt finance the initial operation, with responses to enquiries largely positive to date.
ABR is seeking to commence a formal engagement process in the current quarter, with a view to being fully financed by Q4 CY2019.
A summary of the financial metrics of the starter project and broader operations can be found below.
American Pacific Borate and Lithium is focused on advancing its 100% owned Fort Cady Borate Project located in southern California.
Fort Cady is a highly rare and large colemanite deposit and is the largest known contained borate occurrence in the world not owned by the major borate producers in Rio Tinto and Eti Maden.
When the experts at Next Investors have a stock pick, it may pay to listen.
The Next Investors have been investing in ASX small cap stocks for years, with their best small cap picks yielding returns of 1,200%, 1,120%, 900% and 678%.
They have just revealed their hand-picked, FY2021 stock portfolio of high conviction long-term investments.
Click the link below to see what they are currently investing in.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.